[go: up one dir, main page]

UA27779C2 - Фармацевтична композиція для лікування зайвої ваги або ожиріння, спосіб лікування цією композицією та спосіб поліпшення якості туші свійської тварини - Google Patents

Фармацевтична композиція для лікування зайвої ваги або ожиріння, спосіб лікування цією композицією та спосіб поліпшення якості туші свійської тварини

Info

Publication number
UA27779C2
UA27779C2 UA93004254A UA93004254A UA27779C2 UA 27779 C2 UA27779 C2 UA 27779C2 UA 93004254 A UA93004254 A UA 93004254A UA 93004254 A UA93004254 A UA 93004254A UA 27779 C2 UA27779 C2 UA 27779C2
Authority
UA
Ukraine
Prior art keywords
treatment
overweight
obesity
meat
improvement
Prior art date
Application number
UA93004254A
Other languages
English (en)
Russian (ru)
Inventor
Арне Аструп
Original Assignee
Нукомед Дак А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нукомед Дак А/С filed Critical Нукомед Дак А/С
Publication of UA27779C2 publication Critical patent/UA27779C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Винахід належить до фармацевтичної композиції, що включає прямий або непрямий β-адренергічний агоніст, наприклад, ефедрин, ксантин, кофеїн. Воно стосується також застосування її для лікування від надлишкової ваги або ожиріння, а також для поліпшення якості м'яса свійських тварин при надлишковому вмісті в ньому жиру. 1
UA93004254A 1989-07-07 1990-04-20 Фармацевтична композиція для лікування зайвої ваги або ожиріння, спосіб лікування цією композицією та спосіб поліпшення якості туші свійської тварини UA27779C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK339289A DK339289D0 (da) 1989-07-07 1989-07-07 Farmaceutisk praeparat
PCT/DK1990/000106 WO1991000730A1 (en) 1989-07-07 1990-04-20 A slimming pharmaceutical composition

Publications (1)

Publication Number Publication Date
UA27779C2 true UA27779C2 (uk) 2000-10-16

Family

ID=8122369

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93004254A UA27779C2 (uk) 1989-07-07 1990-04-20 Фармацевтична композиція для лікування зайвої ваги або ожиріння, спосіб лікування цією композицією та спосіб поліпшення якості туші свійської тварини

Country Status (19)

Country Link
US (1) US5422352A (uk)
EP (1) EP0480934B1 (uk)
JP (1) JP2584899B2 (uk)
KR (1) KR0159045B1 (uk)
AT (1) ATE107858T1 (uk)
AU (1) AU638992B2 (uk)
CA (1) CA2063598C (uk)
DE (1) DE69010336T2 (uk)
DK (2) DK339289D0 (uk)
ES (1) ES2055911T3 (uk)
FI (1) FI920026A0 (uk)
HK (1) HK1001821A1 (uk)
HU (1) HU220071B (uk)
LT (1) LT3536B (uk)
LV (1) LV10192B (uk)
NO (1) NO920051L (uk)
RU (1) RU2109511C1 (uk)
UA (1) UA27779C2 (uk)
WO (1) WO1991000730A1 (uk)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5865869A (en) * 1991-08-02 1999-02-02 Ecologel Usa, Inc. Solution for plant root watering
WO1994000432A1 (en) * 1992-06-30 1994-01-06 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anorectic epinephrine derivatives
JPH08509203A (ja) * 1992-10-15 1996-10-01 ダナ−ファーバー キャンサー インステテュート インコーポレイテッド ＴＮＦ−α作用の拮抗剤を用いる肥満関連糖尿病▲ＩＩ▼型のインスリン耐性の治療
ES2094687B1 (es) * 1994-08-02 1997-12-16 S A L V A T Lab Sa Combinacion farmaceutica contra la obesidad o el sobrepeso.
FR2746644A1 (fr) * 1996-03-18 1997-10-03 Firion Jackie Produit parapharmaceutique moderateur d'appetit
CA2248854C (en) * 1996-09-30 2004-03-30 Dennis Jones The regulation of appetite, body weight and athletic function with materials derived from citrus varieties
US6224873B1 (en) 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
ES2259806T5 (es) 1996-12-23 2009-05-01 S.L.A. Pharma Ag Composicion farmaceutica para tratar la incontinencia fecal.
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US7232830B2 (en) 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
AU744550B2 (en) 1998-06-26 2002-02-28 Elaine A. Delack Treatment for multiple sclerosis
US6340482B1 (en) * 2000-05-18 2002-01-22 Zhishin, Llc Methods for inducing weight loss in a human with materials derived from Citrus varieties
US6113949A (en) * 1998-10-27 2000-09-05 Prolab Nutrition, Inc. Weight control product and method of treating hyperlipidemia and increasing vigor with said product
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US6576272B1 (en) * 1999-03-05 2003-06-10 Twin Laboratories Incorporated Dietary supplement and method of using same
WO2001005356A2 (en) * 1999-07-20 2001-01-25 Natrol, Inc. Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant
WO2001013935A2 (en) * 1999-08-23 2001-03-01 The Administrators Of The Tulane Educational Fund Modulation of the blood-brain barrier transporter for leptin
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
DE10011541A1 (de) * 2000-03-06 2001-09-20 Reimann Hartmut Verwendung einer Kombination aus Ephedrin und Coffein und/oder Theophyllin zur Vitalisierung von Knochenfischen, Wasserzusatz zur Vitalisierung von Knochenfischen
US6316499B1 (en) 2000-05-18 2001-11-13 Zhishin, Llc Methods for increasing the muscle mass of a human with materials derived from citrus varieties
KR20030005204A (ko) * 2000-12-25 2003-01-17 가부시키가이샤 시세이도 교감신경 활성화 향료 조성물
US7048941B2 (en) * 2001-03-30 2006-05-23 New World Enterprizes, Inc. Chocolate composition as delivery system for nutrients and medications
US7041305B2 (en) * 2001-09-07 2006-05-09 Western Holdings, Llc Stable water in oil aminophylline emulsions
GB0130763D0 (en) 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
WO2003088953A2 (en) * 2002-04-19 2003-10-30 N.V. Nutricia Multiphasic diet
US8142810B2 (en) * 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
US20040224031A1 (en) * 2003-05-06 2004-11-11 Antonio Zorzano Olarte Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus
US20050130933A1 (en) * 2003-10-17 2005-06-16 Ira Jacobs Weight-loss supplement
CA2545559A1 (en) * 2003-11-20 2005-06-09 Alteragon Pty Ltd. Method of decreasing fat deposits and body weight in mammals and birds
CA2455248A1 (en) * 2004-01-29 2005-07-29 Alexander Zolotoy Oral administration of r-albuterol against obesity
US7524064B2 (en) * 2004-03-09 2009-04-28 Research Foundation Of The State University Of New York Apparatus and method for assessing retinal damage
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20060134230A1 (en) * 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US20060204599A1 (en) * 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US9610429B2 (en) * 2010-12-29 2017-04-04 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with targeted substance delivery
AU2013330213B2 (en) * 2012-10-08 2016-04-14 Rivalea (Australia) Pty Ltd Animal feed supplement comprising ractopamine and caffeine
US9877434B2 (en) 2013-05-30 2018-01-30 Ecologel Solutions, Llc Granular compositions and methods for drought mitigation
US10143664B2 (en) * 2014-03-26 2018-12-04 Rivalea (Australia) Pty Ltd Method for improving feed efficiency in ruminants
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
MX2017010321A (es) 2015-02-13 2017-12-07 Mars Inc Sistema de alimentacion para mascotas.
WO2016167855A1 (en) * 2015-04-14 2016-10-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Combination of albuterol and caffeine as synergistic treatment for obesity or sarcopenia
GB201522296D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat
AU2020276619A1 (en) 2019-05-16 2021-12-16 Nexus Pharmaceuticals, Inc. Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390164A1 (fr) * 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
NL7710582A (nl) * 1977-06-03 1978-12-05 Pharmaceutical Export Promotio Werkwijze ter bereiding van een vermagerings- preparaat.
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5011843A (en) * 1988-05-31 1991-04-30 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors

Also Published As

Publication number Publication date
EP0480934A1 (en) 1992-04-22
LV10192A (lv) 1994-10-20
DE69010336D1 (de) 1994-08-04
RU2109511C1 (ru) 1998-04-27
HU9200051D0 (en) 1992-06-29
DK0480934T3 (da) 1994-11-07
WO1991000730A1 (en) 1991-01-24
AU638992B2 (en) 1993-07-15
NO920051D0 (no) 1992-01-03
LTIP702A (en) 1995-01-31
EP0480934B1 (en) 1994-06-29
HU220071B (hu) 2001-10-28
CA2063598C (en) 1997-12-09
CA2063598A1 (en) 1991-01-08
DK339289D0 (da) 1989-07-07
DE69010336T2 (de) 1994-11-03
US5422352A (en) 1995-06-06
LT3536B (en) 1995-11-27
LV10192B (en) 1995-06-20
FI920026A0 (fi) 1992-01-03
JP2584899B2 (ja) 1997-02-26
AU5630890A (en) 1991-02-06
ATE107858T1 (de) 1994-07-15
ES2055911T3 (es) 1994-09-01
KR0159045B1 (ko) 1998-12-01
HK1001821A1 (en) 1998-07-10
JPH04507091A (ja) 1992-12-10
NO920051L (no) 1992-01-31
HUT62798A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
UA27779C2 (uk) Фармацевтична композиція для лікування зайвої ваги або ожиріння, спосіб лікування цією композицією та спосіб поліпшення якості туші свійської тварини
FR2678624B1 (uk)
ATE110255T1 (de) Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums.
HU905682D0 (en) Early ejaculation treatment by using sertraline
DE69521796D1 (de) Behandlung des partiellen wachstumshormon-unempfindlichkeitssyndromes
CA2001572A1 (en) Compositions for treating tobacco withdrawal symptoms
EP1598054A3 (en) Non-therapeutic methods of suppressing appetite
EP0342956A3 (en) Use of phytic acid or its salts for the treatment of hyperlipemia, obesity and obesity-related diseases
GB8622618D0 (en) Treatment of obesity
NZ314485A (en) stress-relieving livestock food containing yeast and glutathione
EP0813409A4 (en) TREATMENT OF DISEASES CAUSED BY THE CYTOKIN GROWTH FACTOR
JPS57126420A (en) Drug for digestive organ
HU9202274D0 (en) Medical preparative for treating excitement and disturbances of nervous functions
AU1829195A (en) Energy formulation
AU2577492A (en) Preparation of dietary fatty acid salt products
BG60542B2 (en) Water soluble composition having coccidiostatic effect
Karpenko et al. Effects of Changes in Salinity on the Rate of Protein Synthesis in the Tissue of Estuarine Molluscs Nuttallia olivacea and Ruditapes philippinarum(Vliyanie Izmeneniya Solenosti Sredy na Skorost' Sinteza Belka v Tkanyakh Estuarnykh Mollyuskov Nuttallia olivacea i Ruditapes philippinarum)
BG49742A1 (en) Affrodisiance means
HUP9803039A2 (hu) Az elhízás kezelésére, megelőzésére, szövődményei kialakulásának kivédésére, a kialakult szövődmények kezelésére szolgáló gyógyászati kompozíció
Hamosh Creamatocrit and pH measurements of human milk.
Archimbault et al. Chloramphenicol in poultry: Residue study following oral administration.
ES296580U (es) Clavo para la osteosintesis de las fracturas de huesos
HU913262D0 (en) Process for the production of an effective production increasing and animal health improving fodder, and its use in fodder mixtures
EP0408805A3 (en) Flavor delivery system for fat free foods
IL68559A (en) Process for enhancing the level of physiologically active protein in an animal and compositions comprising physiologically active protein